| 000 | 01733 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515215646.0 | ||
| 264 | 0 | _c20110124 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1744-764X | ||
| 024 | 7 |
_a10.1517/14740331003767395 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Xia | |
| 245 | 0 | 0 |
_aTherapeutic drug monitoring in highly active antiretroviral therapy. _h[electronic resource] |
| 260 |
_bExpert opinion on drug safety _cSep 2010 |
||
| 300 |
_a743-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aDrugs, Chinese Herbal _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xcomplications |
| 650 | 0 | 4 |
_aLiver Diseases _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Infectious _xdrug therapy |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
| 700 | 1 | _aMa, Qing | |
| 700 | 1 | _aZhang, Fujie | |
| 773 | 0 |
_tExpert opinion on drug safety _gvol. 9 _gno. 5 _gp. 743-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14740331003767395 _zAvailable from publisher's website |
| 999 |
_c19711136 _d19711136 |
||